BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
939 results:

  • 1. [Curative effect of percutaneous microwave ablation therapy on hepatocellular carcinoma survival: a 15-year real-world study].
    Luo YC; Lang ML; Cai WJ; Han ZY; Liu FY; Cheng ZG; Yu XL; Dou JP; Li X; Tan SL; Dong XJ; Liang P; Yu J
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):332-339. PubMed ID: 38733188
    [No Abstract]    [Full Text] [Related]  

  • 2. Dual Drug Repurposing: The Example of Saracatinib.
    Ramos R; Vale N
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674150
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
    Burton A; Wilburn J; Driver RJ; Wallace D; McPhail S; Cross TJS; Rowe IA; Marshall A
    Br J Cancer; 2024 Jun; 130(10):1697-1708. PubMed ID: 38499728
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Lucas MR; Atkins JL; Pilling LC; Shearman JD; Melzer D
    BMJ Open; 2024 Mar; 14(3):e081926. PubMed ID: 38479735
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Classification and Diagnostic Prediction of Colorectal cancer Mortality Based on Machine Learning Algorithms: A Multicenter National Study.
    Mohammadi G; Azizmohammad Looha M; Pourhoseingholi MA; Rezaei Tavirani M; Sohrabi S; Zareie Shab Khaneh A; Piri H; Alaei M; Parvani N; Vakilzadeh I; Javadi S; Moradian Haft Cheshmeh Z; Razzaghi Z; Robati RM; Zamanian Azodi M; Zarean Shahraki S; Hadavi M; Talebi R; Yazdani JC; Motlagh ME; Khodakarim S
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):333-342. PubMed ID: 38285801
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
    Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma.
    Lee M; Shin HP
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138277
    [No Abstract]    [Full Text] [Related]  

  • 8. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany.
    Thoduka SG; Flegar L; Groeben C; Huber J; Eisenmenger N; Paulus T; Vogt K; Luster M; Abolmaali N
    Curr Oncol; 2023 Dec; 30(12):10325-10335. PubMed ID: 38132386
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
    Chang Y; Yu SJ; Kim HC; Lee YB; Cho EJ; Lee JH; Kim YJ; Chung JW; Yoon JH
    Gut Liver; 2024 Jan; 18(1):156-164. PubMed ID: 38013475
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical impact of sarcopenia in early-stage intrahepatic recurrent hepatocellular carcinoma: an association with impaired host immunity.
    Doi S; Yasuda S; Matsuo Y; Sakata T; Nishiwada S; Nagai M; Nakamura K; Terai T; Kohara Y; Sho M
    Langenbecks Arch Surg; 2023 Nov; 408(1):433. PubMed ID: 37950033
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metabolic Dysfunction-Associated Steatotic liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
    Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liu CH; Liao SH; Hong CM; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):581-590.e6. PubMed ID: 37871842
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Decision to perform additional surgery after non-curative endoscopic submucosal dissection for gastric cancer based on the risk of lymph node metastasis: a long-term follow-up study.
    Lee S; Kim SG; Cho SJ
    Surg Endosc; 2023 Oct; 37(10):7738-7748. PubMed ID: 37567980
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal cancer for liver Transplant: A Nonrandomized Controlled Trial.
    Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
    JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Comparison of Microwave Ablation and Cryoablation for the treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-analysis.
    McClure T; Lansing A; Ferko N; Wright G; Ghosh SK; Raza S; Kalsekar I; Clarke K; Talenfeld A
    Urology; 2023 Oct; 180():1-8. PubMed ID: 37331485
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Adjuvant hepatic artery infusion pump chemotherapy for resected colorectal cancer liver metastases.
    Standring O; Gholami S
    Surgery; 2023 Sep; 174(3):747-749. PubMed ID: 37321884
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B.
    Huang SC; Su TH; Tseng TC; Chen CL; Hsu SJ; Liao SH; Hong CM; Liu CH; Lan TY; Yang HC; Liu CJ; Chen PJ; Kao JH
    Hepatol Int; 2023 Oct; 17(5):1139-1149. PubMed ID: 37247045
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.
    Allignet B; Merle P; Rode A; Mabrut JY; Mohkam K; Mornex F
    Cancer Radiother; 2023 Jun; 27(4):296-302. PubMed ID: 37150729
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. "Long-term follow-up of liver transplantation in incidental intrahepatic cholangiocarcinoma and mixed hepatocellular-cholangiocarcinoma".
    Garcia-Moreno V; Justo-Alonso I; Fernandez-Fernandez C; Rivas-Duarte C; Aranda-Romero B; Loinaz-Segurola C; Jimenez-Romero C; Caso-Maestro Ó
    Cir Esp (Engl Ed); 2023 Sep; 101(9):624-631. PubMed ID: 37119950
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis.
    Shepherdson M; Kilburn D; Ullah S; Price T; Karapetis CS; Nguyen P; Townsend A; Padbury R; Piantadosi C; Maddern G; Carruthers S; Roder D; Sorich M; Roy AC
    ANZ J Surg; 2023; 93(7-8):1847-1853. PubMed ID: 37079715
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 47.